
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Washington-While several major health issues that were sidetrackedby the Sept. 11 terrorist attacks are poised for consideration by Congresswhen it returns to action this month, lobbyists for urologists and otherphysician groups were working hard at press time to prevent a reductionin 2002 Medicare fees.





